Document Detail

Stroke after cardiac surgery: a retrospective analysis of the effect of aprotinin dosing regimens.
MedLine Citation:
PMID:  12607657     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Half-dose aprotinin (HDA) appears to be equivalent to full-dose aprotinin (FDA) in its ability to prevent bleeding. However, data regarding the potential effect of aprotinin use and dosage on other outcomes such as the occurrence of perioperative stroke are limited. It has been postulated that the higher level of kallikrein inhibition obtained with FDA dosing may be required for end-organ protection. Therefore, we performed a retrospective study in cardiac surgery patients at high risk for developing stroke to determine the relative effects of FDA and HDA regimens on the incidence of postoperative stroke. METHODS: Records of 1,524 patients undergoing cardiac surgery over a 15-month period were reviewed. Patients at high risk for stroke were selected if they met all of the following predefined criteria: age greater than 70 years, history of hypertension, history of diabetes mellitus, history of stroke or transient ischemic attack, and presence of aortic atheroma. A validated preoperative stroke risk index was calculated for each patient. Postoperative stroke required confirmation by computed tomography or magnetic resonance imaging. Patients were divided into three groups according to whether they were administered no aprotinin, HAD, or FDA. RESULTS: A total of 149 patients fulfilled the criteria for being at high risk for stroke. Stroke risk index was very similar (p = 0.56) in the three groups: those who received no aprotinin and served as a control group (124 +/- 15, n = 56), those who were given HDA (123 +/- 12, n = 67), and those who received FDA (122 +/- 11 n = 26). Preoperative and intraoperative characteristics were also similar between the three study groups. Overall, the incidence of stroke was 16% (24/149). The incidence of stroke differed (p < 0.05) among the three groups: no aprotinin 16% (9/56), HDA 22% (15/67), and FDA 0% (0/26). CONCLUSIONS: In this retrospective study of cardiac surgery patients at high risk for postoperative stroke, the administration of FDA but not HDA was associated with a lower incidence of stroke.
Robert J Frumento; Catherine M N O'Malley; Elliott Bennett-Guerrero
Related Documents :
2204737 - Is routine duplex examination after carotid endarterectomy justified?
16244487 - Intravenous tpa for very old stroke patients.
1773267 - The radiological (ct) and clinical sequelae of primary intracerebral haemorrhage.
16051897 - Use of multimodal mri and novel endovascular therapies in a patient ineligible for intr...
15045037 - New additions to the intensive care armamentarium.
8448967 - Reduced failure rate in knee prosthetic surgery with improved implantation technique.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  75     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2003 Feb 
Date Detail:
Created Date:  2003-02-27     Completed Date:  2003-03-17     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  479-83; discussion 483-4     Citation Subset:  AIM; IM    
Department of Anesthesiology, Columbia University College of Physicians and Surgeons, New York, New York 10032-3784, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aprotinin / administration & dosage*
Cardiac Surgical Procedures / adverse effects*
Hemostatics / administration & dosage*
Retrospective Studies
Risk Assessment
Serine Proteinase Inhibitors / administration & dosage*
Stroke / etiology,  prevention & control*
Reg. No./Substance:
0/Hemostatics; 0/Serine Proteinase Inhibitors; 9087-70-1/Aprotinin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients.
Next Document:  Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascul...